RELEASE 17.12.2014 SHARES
Exchange | Orderbook Code | Issuer Long Name | ISIN | Current Segment | New List |
XSTO | AERO B | Aerocrine AB ser B | SE0000434292 | Mid Cap | Small Cap |
XSTO | BETS B | Betsson AB ser B | SE0005936911 | Mid Cap | Large Cap |
XSTO | BALD B | Fastighets AB Balder ser B | SE0000455057 | Mid Cap | Large Cap |
XSTO | BALD PREF | Fastighets AB Balder pref | SE0003949973 | Mid Cap | Large Cap |
XSTO | BEF SDB | Black Earth Farming Ltd. SDB | SE0001882291 | Mid Cap | Small Cap |
XSTO | HMS | HMS Networks AB | SE0002136242 | Small Cap | Mid Cap |
XSTO | INDT | Indutrade AB | SE0001515552 | Mid Cap | Large Cap |
XSTO | LIFCO B | Lifco AB ser B | SE0006370730 | Mid Cap | Large Cap |
XSTO | LOOM B | Loomis AB ser B | SE0002683557 | Mid Cap | Large Cap |
XSTO | MYCR | Mycronic AB | SE0000375115 | Small Cap | Mid Cap |
XSTO | NOBI | Nobia AB | SE0000949331 | Mid Cap | Large Cap |
XSTO | OASM | Oasmia Pharmaceutical AB | SE0000722365 | Small Cap | Mid Cap |
XSTO | TWW | Transcom WorldWide AB | SE0006055257 | Small Cap | Mid Cap |
XSTO | VBG B | VBG GROUP AB ser B | SE0000115107 | Small Cap | Mid Cap |
XSTO | VITR | Vitrolife AB | SE0000816043 | Small Cap | Mid Cap |
XHEL | BTH1V | Biotie Therapies Oyj | FI0009011571 | Mid Cap | Small Cap |
XHEL | CTY1S | Citycon Oyj | FI0009002471 | Mid Cap | Large Cap |
XHEL | SDA1V | Sponda Oyj | FI0009006829 | Mid Cap | Large Cap |
XHEL | STCAS | Stockmann Oyj Abp A | FI0009000236 | Large Cap | Mid Cap |
XHEL | STCBV | Stockmann Oyj Abp B | FI0009000251 | Large Cap | Mid Cap |
XHEL | TLV1V | Talvivaaran Kaivososakeyhtiö Oyj | FI0009014716 | Mid Cap | Small Cap |
XCSE | EAC | Det Østasiatiske Kompagni A/S | DK0010006329 | Mid Cap | Small Cap |
XCSE | NRSU | Nørresundby Bank A/S | DK0060135549 | Small Cap | Mid Cap |
XCSE | PAAL B | Per Aarsleff B A/S | DK0010243450 | Small Cap | Mid Cap |
XCSE | RBREW | Royal UNIBREW A/S | DK0010242999 | Mid Cap | Large Cap |
XCSE | VELO | Veloxis Pharmaceuticals A/S | DK0060048148 | Small Cap | Mid Cap |
The segment Large Cap includes companies whose shares have a market value of 1 billion euro or more. In the segment Mid Cap companies whose shares have a market value between 150 million euro and 1 billion euro are included and the segment Small Cap includes companies whose shares have a market value of less than 150 million euro.
The next Market Cap-segment revision will take effect in January 2016 based on market value in November 2015.
For further information concerning this exchange notice please call Corporate Client Group,
Peter Legind-Hansen telephone +45 33 77 03 88
Nasdaq Copenhagen
Corporate Client Group